BindingDB logo
myBDB logout

112 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
27997171 48 Pyrimidine-Based Inhibitors of Dynamin I GTPase Activity: Competitive Inhibition at the Pleckstrin Homology Domain.EBI The University of Newcastle
2153204 6 Assessment of the in vivo and in vitro opioid activity of bridged hexahydroaporphine and isoquinoline molecules.EBI Creighton University
2709383 39 Synthesis and pharmacological evaluation of 4,4-disubstituted piperidines.EBI Anaquest Pharmaceuticals
2536439 10 Synthesis and biological evaluation of 14-alkoxymorphinans. 2. (-)-N-(cyclopropylmethyl)-4,14-dimethoxymorphinan-6-one, a selective mu opioid receptor antagonist.EBI University of Innsbruck
3039139 3 X-ray crystal structure of the opioid ligand naltrexonazine.EBI TBA
3012085 3 Probes for narcotic receptor mediated phenomena. 12. cis-(+)-3-Methylfentanyl isothiocyanate, a potent site-directed acylating agent for delta opioid receptors. Synthesis, absolute configuration, and receptor enantioselectivity.EBI TBA
3009813 3 Probes for narcotic receptor mediated phenomena. 9. Synthesis of (+/-)-(3 alpha,6a alpha,11a beta)-1,3,4,5,6,11a-hexahydro-2-methyl-2H-3,6a- methanobenzofuro[2,3-c]azocin-10-ol, an oxide-bridged 5-(m-hydroxyphenyl)morphan.EBI TBA
3023609 14 Probes for narcotic receptor mediated phenomena. 13. Potential irreversible narcotic antagonist-based ligands derived from 6,14-endo-ethenotetrahydronororipavine with 7-(methoxyfumaroyl)amino, (bromoacetyl)amino, or isothiocyanate electrophiles: chemistry, biochemistry, and pharmacology.EBI TBA
2876106 6 3,7-Diazabicyclane: a new narcotic analgesic.EBI TBA
3020246 11 Irreversible blockage of opioid receptor types by ester homologues of beta-funaltrexamine.EBI TBA
2863378 7 Acylmorphinans. A novel class of potent analgesic agents.EBI TBA
2409280 35 Opioid agonists and antagonists. 6-Desoxy-6-substituted lactone, epoxide, and glycidate ester derivatives of naltrexone and oxymorphone.EBI TBA
2999399 4 Novel nonnarcotic analgesics with an improved therapeutic ratio. Structure-activity relationships of 8-(methylthio)- and 8-(acylthio)-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines.EBI TBA
6094809 32 Synthesis and biological evaluation of 14-alkoxymorphinans. 1. Highly potent opioid agonists in the series of (-)-14-methoxy-N-methylmorphinan-6-ones.EBI TBA
6315939 2 14 beta-(2-bromoacetamido)morphine and 14 beta-(2-bromoacetamido)morphinone.EBI TBA
6600791 32 Synthesis and pharmacological studies of 4,4-disubstituted piperidines: a new class of compounds with potent analgesic properties.EBI TBA
6288945 28 Potential affinity labels for the opiate receptor based on fentanyl and related compounds.EBI TBA
6276546 12 Common anionic receptor site hypothesis: its relevance to the antagonist action of naloxone.EBI TBA
6268789 22 Synthesis of analogues of acetylmethadol and methadol as potential narcotic antagonists.EBI TBA
6268786 27 Opiate receptor interaction of compounds derived from or structurally related to fentanyl.EBI TBA
6273560 16 Preparation and analgesic properties of amino acid derivatives of (-)-5,9 alpha-diethyl-2'-hydroxybenzomorphan.EBI TBA
6249930 7 Synthesis and analgesic activity of some 5-(4-hydroxyphenyl)-2-azabicyclo[3.2.1]octanes.EBI TBA
6248644 4 Some spiro analogues of the potent analgesic ketobemidone.EBI TBA
26988801 55 Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.EBI Jagiellonian University Medical College
26656913 85 Multitarget opioid ligands in pain relief: New players in an old game.EBI University of Catania
26491810 35 Structure-Activity Relationships of the Peptide Kappa Opioid Receptor Antagonist Zyklophin.EBI The University of Kansas
25593096 65 Potency enhancement of theż-opioid receptor antagonist probe ML140 through sulfonamide constraint utilizing a tetrahydroisoquinoline motif.EBI University of Kansas Specialized Chemistry Center
25513968 21 Novel fluoroalkyl derivatives of selective kappa opioid receptor antagonist JDTic: Design, synthesis, pharmacology and molecular modeling studies.EBI Universit£
25221662 24 Novel cyclic biphalin analogue with improved antinociceptive properties.EBI Universit£
23360448 18 Development of¿ opioid receptor antagonists.EBI Research Triangle Institute
22677527 38 Deconstructing 14-phenylpropyloxymetopon: minimal requirements for binding to mu opioid receptors.EBI University of Maryland
18403056 8 Ligand binding to nucleic acids and proteins: Does selectivity increase with strength?EBI Universit£T Des Saarlandes
18293909 5 Toward a structure-based model of salvinorin A recognition of the kappa-opioid receptor.EBI University of Minnesota
16033285 24 Effect of a 6-cyano substituent in 14-oxygenated N-methylmorphinans on opioid receptor binding and antinociceptive potency.EBI University of Innsbruck
12954070 24 Synthesis and biological evaluation of 14-alkoxymorphinans. 20. 14-phenylpropoxymetopon: an extremely powerful analgesic.EBI University of Innsbruck
11300879 77 Factors influencing agonist potency and selectivity for the opioid delta receptor are revealed in structure-activity relationship studies of the 4-[(N-substituted-4-piperidinyl)arylamino]-N,N-diethylbenzamides.EBI Research Triangle Institute
11300867 32 Investigation of the selectivity of oxymorphone- and naltrexone-derived ligands via site-directed mutagenesis of opioid receptors: exploring the"address" recognition locus.EBI University of Minnesota
11405645 13 Transformation of a kappa-opioid receptor antagonist to a kappa-agonist by transfer of a guanidinium group from the 5'- to 6'-position of naltrindole.EBI University of Minnesota
10753461 13 Isosteric replacement of acidic with neutral residues in extracellular loop-2 of the kappa-opioid receptor does not affect dynorphin A(1-13) affinity and function.EBI University of Minnesota
10841791 8 Modeling of kappa-opioid receptor/agonists interactions using pharmacophore-based and docking simulations.EBI Universit£
9836606 12 Mutational evidence for a common kappa antagonist binding pocket in the wild-type kappa and mutant mu[K303E] opioid receptors.EBI University of Minnesota
9804688 51 Modified ibogaine fragments: synthesis and preliminary pharmacological characterization of 3-ethyl-5-phenyl-1,2,3,4,5, 6-hexahydroazepino[4,5-b]benzothiophenes.EBI University of Minnesota
9719602 24 3-Alkyl ethers of clocinnamox: delayed long-term mu-antagonists with variable mu efficacy.EBI University of Bristol
2167979 43 Photoactivatable opiate derivatives as irreversible probes of the mu-opioid receptor.EBI Universit£
2536436 24 Cyclic enkephalin analogues containing alpha-amino-beta-mercapto-beta,beta-pentamethylenepropionic acid at positions 2 or 5.EBI Smith Kline and French Laboratories
2888899 34 Combined analgesic/neuroleptic activity in N-butyrophenone prodine-like compounds.EBI Istituto Superiore Di Sanit£
3007760 93 N-substituent modulation of opiate agonist/antagonist activity in resolved 3-methyl-3-(m-hydroxyphenyl)piperidines.EBI TBA
10782696 67 ORL1 receptor ligands: structure-activity relationships of 8-cycloalkyl-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-ones.EBI F. Hoffmann-La Roche
11078198 12 N-Cyclohexylethyl-N-noroxymorphindole: a mu-opioid preferring analogue of naltrindole.EBI University of Maryland
9873480 35 Syntheses of potent Leu-enkephalin analogs possessing beta-hydroxy-alpha,alpha-disubstituted-alpha-amino acid and their characterization to opioid receptors.EBI Institute For Bioorganic Research
 17 Synthesis and biological evaluation of 14-alkoxymorphinans. 14.1 14-ethoxy-5-methyl substituted indolomorphinans with opioid receptor selectivityEBI TBA
20692738 34 Synthesis and activity of endomorphin-2 and morphiceptin analogues with proline surrogates in position 2.EBI Sapienza University of Rome
20591666 66 A new group of oxime carbamates as reversible inhibitors of fatty acid amide hydrolase.EBI Università
20144865 18 Synthesis and evaluation of opioid receptor-binding affinity of elaeocarpenine and its analogs.EBI Kyorin Pharmaceutical
19646882 72 Novel delta opioid receptor agonists exhibit differential stimulation of signaling pathways.EBI University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School and The Informatics Institute of Umdnj
19807094 45 The effects of C-terminal modifications on the opioid activity of [N-benzylTyr(1)]dynorphin A-(1-11) analogues.EBI University of Kansas
19715279 20 Design, synthesis, and pharmacological activities of dynorphin A analogues cyclized by ring-closing metathesis.EBI The University of Kansas
 17 trans N-Methyl-N-[2-(1-pyrrolidinyl)cyclohexyl] cycloprop-2-ene-1-carboxamides: Novel lipophilic kappa opioid agonistsEBI TBA
 35 Stereoselective synthesis and evaluation of all stereoisomers of Z4349, a novel and selective μ-opioid analgesicEBI TBA
17303418 8 Convenient synthesis and in vitro pharmacological activity of 2-thioanalogs of salvinorins A and B.EBI University of Mississippi
15658846 13 Studies toward the pharmacophore of salvinorin A, a potent kappa opioid receptor agonist.EBI The University of Melbourne
15163203 45 Synthesis and biological evaluation of 14-alkoxymorphinans. 21. Novel 4-alkoxy and 14-phenylpropoxy derivatives of the mu opioid receptor antagonist cyprodime.EBI University of Innsbruck
14736254 70 Structure-activity study on the Phe side chain arrangement of endomorphins using conformationally constrained analogues.EBI Biological Research Center of The Hungarian Academy of Sciences
14711314 63 Synthesis and opioid activity of side-chain-to-side-chain cyclic dynorphin A-(1-11) amide analogues cyclized between positions 2 and 5. 1. Substitutions in position 3.EBI University of Maryland
12954053 39 Effects of the substitution of Phe4 in the opioid peptide [D-Ala8]dynorphin A-(1-11)NH2.EBI University of Maryland
12672238 3 Mechanism of action of the diazabicyclononanone-type kappa-agonists.EBI UniversitäT WüRzburg
12372527 27 Opioid activity of 4-imidazolidinone positional analogues of Leu-Enkephalin.EBI Institute For Molecular Studies
12161117 2 3-Pyrroline containing arylacetamides: a novel series of remarkably selective kappa-agonists.EBI Chinese Academy of Sciences
32199689 64 Design, synthesis, and biological activity of new endomorphin analogs with multi-site modifications.EBI Lanzhou University
32787075 163 Identification and Optimization of Pyrrolidine Derivatives as Highly Potent Ghrelin Receptor Full Agonists.EBI Astrazeneca
30685525 34 Benzimidazolone-based selective ?EBI University of Florida
10893314 24 Potent and selective indolomorphinan antagonists of the kappa-opioid receptor.EBI University of Minnesota
27624520 24 An LP1 analogue, selective MOR agonist with a peculiar pharmacological profile, used to scrutiny the ligand binding domain.EBI University of Catania
29939744 179 Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure-Functional Selectivity Relationships (SFSRs) and Therapeutic Potential.EBI Shanghaitech University
31498617 29 Discovery of Benzamidine- and 1-Aminoisoquinoline-Based Human MAS-Related G-Protein-Coupled Receptor X1 (MRGPRX1) Agonists.EBI Eisai
9083489 30 Conformationally constrained deltorphin analogs with 2-aminotetralin-2-carboxylic acid in position 3.EBI Hungarian Academy of Sciences
8411007 392 Chemistry, binding affinities, and behavioral properties of a new class of"antineophobic" mitochondrial DBI receptor complex (mDRC) ligands.EBI Mayo Foundation
207868 36 Analgesics. 1. Synthesis and analgesic properties of N-sec-alkyl- and N-tert-alkylnormorphines.EBI TBA
209186 19 Conformation of 2,9-dimethyl-3'-hydroxy-5-phenyl-6,7-genzomorphan and its relation to other analgetics and enkephalin.EBI TBA
206698 2 Studies in the (+)-morphinan series. 5. Synthesis and biological properties of (+)-naloxone.EBI TBA
73588 5 Quantum chemical studies of N-substituent variation in the oxymorphone series of opiate narcotics.EBI TBA
218015 16 Paradoxical effects of N-cyanoalkyl substituents upon the activities of several classes of opioids.EBI TBA
218012 12 Deoxymorphines: role of the phenolic hydroxyl in antinociception and opiate receptor interactions.EBI TBA
109618 9 N-(2-Cyanoethyl) derivatives of meperidine, ketobemidone, and a potent 6,7-benzomorphan.EBI TBA
8246239 84 Development of high-affinity 5-HT3 receptor antagonists. Structure-affinity relationships of novel 1,7-annelated indole derivatives.EBI Solvay Duphar
7908696 45 Enkephalin analogs as systemically active antinociceptive agents: O- and N-alkylated derivatives of the dipeptide amide L-2,6-dimethyltyrosyl-N-(3-phenylpropyl)-D-alaninamide.EBI Searle
6313921 10 Synthesis and pharmacological characterization of (+/-)-5,9 alpha-dimethyl-2-[2-(4-fluorophenyl)ethyl]-2'-hydroxy-6,7-benzomorphan (fluorophen), a ligand suitable for visualization of opiate receptors in vivo.EBI TBA
3746815 15 In vitro labeling of serotonin-S2 receptors: synthesis and binding characteristics of [3H]-7-aminoketanserin.EBI TBA
29273415 15 Design, synthesis, and opioid activity of arodyn analogs cyclized by ring-closing metathesis involving Tyr(allyl).EBI University of Kansas
2153212 87 Cholecystokinin-A receptor ligands based on the kappa-opioid agonist tifluadom.EBI Merck Sharp & Dohme Research Laboratories
28314512 33 Modulation of opioid receptor affinity and efficacy via N-substitution of 9?-hydroxy-5-(3-hydroxyphenyl)morphan: Synthesis and computer simulation study.EBI National Institute On Drug Abuse and The National Institute On Alcohol Abuse
1346276 25 Preparation and opioid activity of analogues of the analgesic dipeptide 2,6-dimethyl-L-tyrosyl-N-(3-phenylpropyl)-D-alaninamide.EBI G.D. Searle And
1323682 61 Novel indolodioxanes with antihypertensive effects: potent ligands for the 5-HT1A receptor.EBI Upjohn
27128978 8 Inhibitor Discovery for the Human GLUT1 from Homology Modeling and Virtual Screening.BDB Icahn School of Medicine At Mount Sinai
26032047 15 Novel 4-heteroaryl-antipyrines as DPP-IV inhibitors.BDB Cairo University
7774675 35 Characterisation of melanocortin receptor subtypes by radioligand binding analysis.BDB Uppsala